相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apoptosis versus axon pruning: Molecular intersection of two distinct pathways for axon degeneration
Matthew J. Geden et al.
NEUROSCIENCE RESEARCH (2019)
Antisense Suppression of Glial Fibrillary Acidic Protein as a Treatment for Alexander Disease
Tracy L. Hagemann et al.
ANNALS OF NEUROLOGY (2018)
Alexander disease: an astrocytopathy that produces a leukodystrophy
Alexander Sosunov et al.
BRAIN PATHOLOGY (2018)
An image-based small-molecule screen identifies vimentin as a pharmacologically relevant target of simvastatin in cancer cells
Kathryn P. Trogden et al.
FASEB JOURNAL (2018)
Tissue and cellular rigidity and mechanosensitive signaling activation in Alexander disease
Liqun Wang et al.
NATURE COMMUNICATIONS (2018)
GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease
Li Li et al.
CELL STEM CELL (2018)
Mutations in GFAP Disrupt the Distribution and Function of Organelles in Human Astrocytes
Jeffrey R. Jones et al.
CELL REPORTS (2018)
Deep nuclear invaginations are linked to cytoskeletal filaments - integrated bioimaging of epithelial cells in 3D culture
Danielle M. Jorgens et al.
JOURNAL OF CELL SCIENCE (2017)
Regulation of genome organization and gene expression by nuclear mechanotransduction
Caroline Uhler et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Isolation of Intermediate Filament Proteins from Multiple Mouse Tissues to Study Aging-associated Post-translational Modifications
Rachel A. Battaglia et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)
The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease
Alexander A. Sosunov et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Intermediate filament dynamics: What we can see now and why it matters
Amelie Robert et al.
BIOESSAYS (2016)
Lamin Dysfunction Mediates Neurodegeneration in Tauopathies
Bess Frost et al.
CURRENT BIOLOGY (2016)
Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system
Elly M. Hol et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
Nitric oxide mediates glial-induced neurodegeneration in Alexander disease
Liqun Wang et al.
NATURE COMMUNICATIONS (2015)
CSF and Blood Levels of GFAP in Alexander Disease
Paige L. Jany et al.
ENEURO (2015)
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
Ye Zhang et al.
JOURNAL OF NEUROSCIENCE (2014)
Post-translational modifications of intermediate filament proteins: mechanisms and functions
Natasha T. Snider et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation
Mei-Hsuan Chen et al.
ASN NEURO (2013)
GFAP expression as an indicator of disease severity in mouse models of Alexander disease
Paige L. Jany et al.
ASN NEURO (2013)
Expression and Activation of Caspase-6 in Human Fetal and Adult Tissues
Nelly Godefroy et al.
PLOS ONE (2013)
Phosphorylation of GFAP is Associated with Injury in the Neonatal Pig Hypoxic-Ischemic Brain
Susan M. Sullivan et al.
NEUROCHEMICAL RESEARCH (2012)
Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines
Christoph Bock et al.
CELL (2011)
The nucleoplasmic reticulum: form and function
Ashraf Malhas et al.
TRENDS IN CELL BIOLOGY (2011)
Cleavage at the 586 Amino Acid Caspase-6 Site in Mutant huntingtin Influences Caspase-6 Activation In Vivo
Rona K. Graham et al.
JOURNAL OF NEUROSCIENCE (2010)
Dominant cataract formation in association with a vimentin assembly disrupting mutation
Martin Mueller et al.
HUMAN MOLECULAR GENETICS (2009)
Introducing intermediate filaments: from discovery to disease
John E. Eriksson et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
IF-pathies: a broad spectrum of intermediate filament-associated diseases
M. Bishr Omary
JOURNAL OF CLINICAL INVESTIGATION (2009)
Disruption of neurofilament network with aggregation of light neurofilament protein: a common pathway leading to motor neuron degeneration due to Charcot-Marie-Tooth disease-linked mutations in NFL and HSPB1
Jinbin Zhai et al.
HUMAN MOLECULAR GENETICS (2007)
Activation of caspase-6 in aging and mild cognitive impairment
Steffen Albrecht et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP
Michael J. Saganich et al.
JOURNAL OF NEUROSCIENCE (2006)
The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of αB-crystallin and HSP27
Ming Der Perng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
'Heads and tails' of intermediate filament phosphorylation: multiple sites and functional insights
M. Bishr Omary et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin
Rona K. Graham et al.
CELL (2006)
Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664
V Galvan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Keratin 8 overexpression promotes mouse Mallory body formation
I Nakamichi et al.
JOURNAL OF CELL BIOLOGY (2005)
Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction
TL Hagemann et al.
HUMAN MOLECULAR GENETICS (2005)
Intermediate filaments control the intracellular distribution of caspases during apoptosis
D Dinsdale et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Active caspase-6 and caspase-6-cleaved Tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease
HS Guo et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome
RD Goldman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome
M Eriksson et al.
NATURE (2003)
Caspase proteolysis of desmin produces a dominant-negative inhibitor of intermediate filaments and promotes apoptosis
F Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Apoptotic threshold is lowered by p53 transactivation of caspase-6
TK MacLachan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation
S Ruchaud et al.
EMBO JOURNAL (2002)
Distribution of phosphorylated glial fibrillary acidic protein in the mouse central nervous system
M Takemura et al.
GENES TO CELLS (2002)
Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis
Y Byun et al.
CELL DEATH AND DIFFERENTIATION (2001)
Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease
M Brenner et al.
NATURE GENETICS (2001)
Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene.
MC Dalakas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
